Boehringer Ingelheim is pumping funds into the still-hot antibody-drug conjugate space, committing 27 million Swiss francs ...

“As part of Cyclacel’s efforts to reduce operating costs, it has determined to focus on the development of plogosertib, a polo-like kinase 1 inhibitor for treatment of advanced cancers and ...

While Pliant Therapeutics and Acelyrin recently blocked ever-eager acquirer Concentra Biosciences with “poison pill” defenses ...

Tesla CEO Elon Musk is expected to step down from his position helming the federal Department of Government Efficiency (DOGE) ...

The cuts impact more than $2.4 billion in grant money, including $1.3 billion in grant funds already spent on projects ...

British biotech CellCentric is settling into a new office in Boston, part of the company’s expansion into the U.S. as ...

The Trump administration is halting research funding to Princeton University and reviewing about $9 billion in federal grants and contracts to Harvard University, the latest escalation of the ...

Medtronic has inked a neurovascular partnership with Methinks AI, a Barcelona, Spain-based developer of programs to detect ...

Following the FDA clearance of its Versius robot last fall, CMR Surgical has posted another major funding round, raising more ...

FDA Chief Medical Officer Hilary Marston, M.D., is leaving her position at the agency.  | The FDA’s Chief Medical Officer ...

Across the study, two patients experienced “serious adverse events of atrial fibrillation (AF) requiring cardioversion,” ...